E
XORTX Therapeutics Inc. XRTX
$2.08 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
6/4/2024 - TipRanks Financial Blog
5/17/2024 - TipRanks Financial Blog
5/17/2024 - TipRanks Financial Blog
4/30/2024 - TipRanks Financial Blog
4/30/2024 - TipRanks Financial Blog
4/8/2024 - TipRanks Financial Blog
4/4/2024 - TipRanks Financial Blog
3/19/2024 - TipRanks Financial Blog
3/11/2024 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 16, 2024
Period Date
Sunday, March 31, 2024
Next Filing
Week of Aug 12 and 16 (est)
Price History
Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Market Cap
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Phone Number
(403) 455-7727
Address
3710 – 33rd Street NW
Alberta Beach, AB T2L 2M1
Country
Year Founded
--
Business Description
Sector
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin... more
Weiss Ratings